Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA
Common Side Effects Experienced by some users Injection site reactions Temporary redness, swelling, or mild pain at injection site Management: Rotate injection sites, ensure proper technique, apply ice if needed Flushing or warmth Brief feeling of warmth or facial flushing shortly after injection Management: Usually resolves within 15-30 minutes, no treatment needed Water retention Mild fluid retention, especially in first few weeks Management: Usually temporary, reduce sodium intake if bothersome Increased appetite GH stimulation can increase hunger Management: Plan meals accordingly, can be beneficial for muscle-building goals Less Common Tingling or numbness Headache These typically resolve with continued use or dose adjustment
10.1021/jasms.0c00116 J
Mechanistic process Cuproptosis is characterized by three core processes: Copper ion delivery and acylation modification, abnormal aggregation of acylated proteins, and proteotoxic stress leading to mitochondrial dysfunction (122,157) (Fig
While your body naturally produces glutathione, it may be challenging to keep optimal levels